Cargando…
Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model
Introduction: Generic pharmaceuticals account for the majority of the $359 billion US pharmaceutical market, including for cardiology drugs. Amidst a lack of price transparency and administrative inefficiencies, generic drug prices are high, causing an undue burden on patients. Methods: We identifie...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506155/ https://www.ncbi.nlm.nih.gov/pubmed/37727389 http://dx.doi.org/10.3389/fphar.2023.1179253 |